Menu
1-702-720-6310 info@microcapspecualtors.com

Microcap Speculators

Here at microcap speculators we are in search of the very best speculative stocks.  The reason why we are so interested in locating the top small cap stocks is because cheap illiquid stocks on Monday could be highly valued liquid stocks the next.  Remember to never invest more into a speculative stock than you can afford to lose, and this is the key because should you be willing to gamble with your principal, it could pay off in a big way for you.

SUBSCRIBE TO OUR MONTHLY NEWSLETTER

Subscribe to our mailing list

* indicates required

Boosts in R&D Spending Drive Biotech Innovation, BDO USA Analysis Finds - CPAPracticeAdvisor.com


Zacks.com
Boosts in R&D Spending Drive Biotech Innovation, BDO USA Analysis Finds
CPAPracticeAdvisor.com
Fueled by a desire for innovation and new medical breakthroughs, the biotech industry continues to enjoy substantial growth due to increased investment in research and development (R&D), according to the sixth annual study from BDO USA, LLP. The 2017 ...
Biotech ETF Industry Outlook for Second Half 2017Zacks.com

all 2 news articles »

read more

Davis biotech firm Marrone Bio makes first product shipments to Africa - Sacramento Bee

Davis biotech firm Marrone Bio makes first product shipments to Africa
Sacramento Bee
Davis biotech firm Marrone Bio Innovations Inc. said Monday that it has shipped its first product to the African continent. MBI said it has shipped its biofungicide, Reysana, to Morocco for use by growers of tomatoes, grapes and cucurbits, a diverse ...

and more »

read more

This Biotech Got A Price Hike, But Seesawed After A Three-Day Run ... - Investor's Business Daily


Investor's Business Daily
This Biotech Got A Price Hike, But Seesawed After A Three-Day Run ...
Investor's Business Daily
Sarepta stock toed the line Monday after a three-day run turned negative following its strong second-quarter report last week and a price-target hike.

and more »

read more

Could This Small Biotech Break Out On A Tie-Up With Eli Lilly? - Investor's Business Daily


Investor's Business Daily
Could This Small Biotech Break Out On A Tie-Up With Eli Lilly?
Investor's Business Daily
Nektar Therapeutics (NKTR) stock neared a breakout Monday after announcing a deal with Eli Lilly (LLY) to develop an drug that could stoke the immune system to fight autoimmune and inflammatory conditions. XAutoplay: On | OffIn morning trading on the ...
Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese FirmTheStreet.com

all 120 news articles »

read more

3 Large-Cap Biotech Stocks to Buy Now - Investorplace.com


Investorplace.com
3 Large-Cap Biotech Stocks to Buy Now
Investorplace.com
Last week was a swell one for the broader market, which saw multiple major indices hit all-time highs. The S&P 500 gained 0.52%, while the Nasdaq-100 tacked on 1.4% and hit uncharted territory. However, the party to watch is not the forest, but the ...

read more

3 Things In Biotech You Should Learn Today: July 24, 2017 - Seeking Alpha


Seeking Alpha
3 Things In Biotech You Should Learn Today: July 24, 2017
Seeking Alpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research!

read more

San Diego cancer biotech raises $38.6 million - The San Diego ... - The San Diego Union-Tribune


The San Diego Union-Tribune
San Diego cancer biotech raises $38.6 million - The San Diego ...
The San Diego Union-Tribune
eFFECTOR Therapeutics seeks to control how proteins are made to treat cancers.

and more »

read more

Risk-On Attitude Drive Stocks and Biotech Higher - Investopedia

Risk-On Attitude Drive Stocks and Biotech Higher
Investopedia
If we use ETFs as a proxy for sectors, then it should come as no surprise that the SPDR S&P 500 Biotech ETF (XBI) is by far the best performer in 2017, up nearly 37 percent. That's followed, in a distant second place, by the Technology Select Sector ...

read more
Search